The menu items for the Office of Ethics and Compliance are not appearing. We hope this issue will soon be resolved.听
You may access the Ethics and Compliance menu under "About"
听
News
Active Startup: Corbin Therapeutics Inc.
Published: 10 October 2019
Business Snapshot
Using a unique drug discovery platform to identify and develop novel inhibitors for treatment of various inflammation diseases, such as multiple sclerosis. This platform includes several in-vitro and in-vivo models for efficient drug screening and confirmation of potential lead candidates.
Target Markets
Inflammation (neuro-inflammation in particular)
Intellectual Property
Granted in Europe, in prosecution elsewhere.
Founder
Philippe Gros